topic

592 Enhancing the therapeutic potential of oncolytic adenoviruses with vSENS™ technology
Goo-Young Kim, Ji Yeon Son, So Jin Lee, Sang Woo Jo, Changhoon In, Sang Hoon Kim, Joon Young Park, So-Young Kim, Gyu-Young Moon, Ji-Hye Choi, Suk-Hwan Kim, Minhyuk Yun, Hye Yeong Nam, Helen Cho

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A354-A355; DOI: 10.1136/jitc-2020-SITC2020.0592
593 Tumoral melanosis mimicking residual melanoma After T-VEC treatment
Song Park, Ata Moshiri, Rouba Hadi, Austin Green, Jennifer Gardner, Coley Doolittle-Amieva

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A355-A356; DOI: 10.1136/jitc-2020-SITC2020.0593
596 Armed myxoma virus demonstrates therapeutic activity in xenograft models
Lino Torres-Dominguez, Lina Franco, Mario Abrantes, Benjamin Walker, Zachary Tacner, Cassandra Kien, Natalie Elliott, Anna Waters, Grant McFadden, Steven Potts, Leslie Sharp

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A356-A357; DOI: 10.1136/jitc-2020-SITC2020.0596
594 BT-001, an oncolytic vaccinia virus armed with a Treg-depleting human recombinant anti-CTLA4 antibody and GM-CSF to target the tumor microenvironment
Monika Semmrich, Jean-Baptiste Marchand, Laetitia Fend, Matilda Rehn, Nathalie Silvestre, Linda Mårtensson, Johann Foloppe, Ingrid Teige, Eric Quéméneur, Björn Frendeus

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A356; DOI: 10.1136/jitc-2020-SITC2020.0594
598 Reversal of epigenetic silencing of cGAS and STING in melanoma enhances the activity of tumor infiltrating lymphocytes
Rana Falahat, James Mulé, Anders Berglund, Patricio Perez- Villarroel, Ryan Putney, Shari Pilon-Thomas, Glen Barber

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A357-A358; DOI: 10.1136/jitc-2020-SITC2020.0598
597 In situ vaccination with oncolytic vesicular stomatitis virus improves anti-tumor immune response and outcome in bladder cancer
Coby Rangsitratkul, Christine Lawson, Lee-Hwa Tai

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A357; DOI: 10.1136/jitc-2020-SITC2020.0597
599 New checkpoints controlling function of cytotoxic lymphocytes infiltrating human carcinoma
Anna Herbstritt, Elfriede Noessner, Petra Prinz, Mani Kadiyala, Melissa Maxwell, Dingxue Yan, James Cardia, Simon Fricker

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A358; DOI: 10.1136/jitc-2020-SITC2020.0599
602 STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
Manoj Chelvanambi, Ronald Fecek, Jennifer Taylor, Walter Storkus

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A359-A360; DOI: 10.1136/jitc-2020-SITC2020.0602
601 Development of improved small molecule STING agonists suitable for systemic administration
Maciej Rogacki, Stefan Chmielewski, Magdalena Zawadzka, Jolanta Mazurek, Katarzyna Wnuk-Lipińska, Kamil Kuś, Karolina Gluza, Katarzyna Wójcik-Jaszczyńska, Aleksandra Poczkaj, Lukasz Dudek, Wojciech Schonemann, Urszula Głowniak-Kwitek, Marcin Leś, Marek Wronowski, Tushar Mahajan, Urszula Kulesza, Magdalena Zastawna, David Synak, Karol Zuchowicz, Katarzyna Banaszak, Karolina Wiatrowska, Izabela Strojny, Mirosława Gładysz, Justyna Jabłońska, Ewelina Gabor-Worwa, Raghuram Tangirala, Luigi Stasi, Peter Littlewood, Krzysztof Brzózka, Monika Dobrzańska

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A359; DOI: 10.1136/jitc-2020-SITC2020.0601
56 Improved next generation sequencing based class I HLA typing through exome enhancement
Lee McDaniel, Rachel Pyke, Charles Abbott, Gabor Bartha, John West, Richard Chen, Sean Boyle

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A36; DOI: 10.1136/jitc-2020-SITC2020.0056

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages